HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome.

Abstract
Deficiency in the serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation. Here we show that the membrane protease matriptase initiates Netherton syndrome in a LEKTI-deficient mouse model by premature activation of a pro-kallikrein cascade. Auto-activation of pro-inflammatory pro-kallikrein-related peptidases that are associated with stratum corneum detachment was either low or undetectable, but they were efficiently activated by matriptase. Ablation of matriptase from LEKTI-deficient mice dampened inflammation, eliminated aberrant protease activity, prevented detachment of the stratum corneum, and improved the barrier function of the epidermis. These results uncover a pathogenic matriptase-pro-kallikrein pathway that could operate in several human skin and inflammatory diseases.
AuthorsKatiuchia Uzzun Sales, Andrius Masedunskas, Alexandra L Bey, Amber L Rasmussen, Roberto Weigert, Karin List, Roman Szabo, Paul A Overbeek, Thomas H Bugge
JournalNature genetics (Nat Genet) Vol. 42 Issue 8 Pg. 676-83 (Aug 2010) ISSN: 1546-1718 [Electronic] United States
PMID20657595 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Serine Proteinase Inhibitors
  • Peptide Hydrolases
  • Kallikreins
  • Serine Endopeptidases
  • matriptase
Topics
  • Animals
  • Epidermis (metabolism, pathology)
  • Humans
  • Inflammation (metabolism, pathology)
  • Kallikreins (metabolism)
  • Mice
  • Netherton Syndrome
  • Peptide Hydrolases (metabolism)
  • Serine Endopeptidases (metabolism)
  • Serine Proteinase Inhibitors (metabolism)
  • Skin (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: